Shalini Sharp is Director of Nuvation Bio Inc.. Currently has a direct ownership of 35,000 shares of NUVB, which is worth approximately $81,900. The most recent transaction as insider was on Feb 10, 2021, when has been sold 10,000 shares (Class A Common Stock) at a price of $10.0 per share, resulting in proceeds of $100,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35K
0% 3M change
0% 12M change
Total Value Held $81,900

Shalini Sharp Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2021
BUY
Grant, award, or other acquisition
$100,000 $10.0 p/Share
10,000 Added 22.22%
35,000 Class A Common Stock
Feb 10 2021
BUY
Exercise of conversion of derivative security
-
25,000 Added 50.0%
25,000 Class A Common Stock

Also insider at

RARE
Ultragenyx Pharmaceutical Inc. Healthcare
DTIL
PRECISION BIOSCIENCES INC Healthcare
MRTX
Mirati Therapeutics, Inc. Healthcare
NBIX
NEUROCRINE BIOSCIENCES INC Healthcare
STRO
SUTRO BIOPHARMA, INC. Healthcare
OGN
Organon & Co. Healthcare
BGNE
BeiGene, Ltd. Healthcare
SS

Shalini Sharp

Director
San Diego, CA

Track Institutional and Insider Activities on NUVB

Follow Nuvation Bio Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVB shares.

Notify only if

Insider Trading

Get notified when an Nuvation Bio Inc. insider buys or sells NUVB shares.

Notify only if

News

Receive news related to Nuvation Bio Inc.

Track Activities on NUVB